Hemostemix Inc. (TSXV:HEM)
Canada · Delayed Price · Currency is CAD 0.0700
-0.0100 (-12.50%)
Aug 28, 2026, 2:50 PM EST
Hemostemix Market Cap
Hemostemix has a market cap or net worth of CAD 15.83 million as of August 28, 2026. Its market cap has increased by 8.87% in one year.
Market Cap
15.83M
Enterprise Value
19.12M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
ChartMarket Cap Chart
Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 15.83M, a decrease of -67.62%. That is a compound annual growth rate of -9.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 15.83M | -9.94% |
| Dec 31, 2025 | 17.57M | 3.39% |
| Dec 31, 2024 | 17.00M | 178.71% |
| Dec 29, 2023 | 6.10M | -55.27% |
| Dec 30, 2022 | 13.63M | 44.06% |
| Dec 31, 2021 | 9.46M | -70.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Resverlogix | 32.71M |
| Lobe Sciences | 28.30M |
| Sharp Therapeutics | 27.37M |
| Devonian Health Group | 27.11M |
| Pharmala Biotech Holdings | 25.12M |
| Alzai Health | 24.06M |
| Rapid Dose Therapeutics | 16.37M |
| PreveCeutical Medical | 15.29M |